Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Martin Zamora to Ganciclovir

This is a "connection" page, showing publications Martin Zamora has written about Ganciclovir.

 
Connection Strength
 
 
 
0.819
 
  1. Kiser TH, Fish DN, Zamora MR. Evaluation of valganciclovir pharmacokinetics in lung transplant recipients. J Heart Lung Transplant. 2012 Feb; 31(2):159-66.
    View in: PubMed
    Score: 0.402
  2. Zamora MR, Nicolls MR, Hodges TN, Marquesen J, Astor T, Grazia T, Weill D. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Am J Transplant. 2004 Oct; 4(10):1635-42.
    View in: PubMed
    Score: 0.242
  3. Zamora MR, Davis RD, Leonard C. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations. Transplantation. 2005 Jul 27; 80(2):157-63.
    View in: PubMed
    Score: 0.064
  4. Zamora MR. Cytomegalovirus and lung transplantation. Am J Transplant. 2004 Aug; 4(8):1219-26.
    View in: PubMed
    Score: 0.060
  5. Zamora MR. Controversies in lung transplantation: management of cytomegalovirus infections. J Heart Lung Transplant. 2002 Aug; 21(8):841-9.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)